Category: Patent Litigation

    By Suresh Pillai — Federal Court Approves Eloxatin® Settlement Agreement The U.S. District Court for the District of New Jersey has signed off on Sanofi-Aventis' settlement agreement with Sun Pharmaceutical Industries Ltd. despite the fact that Sanofi failed to exchange all relevant signature pages.  The agreement ends the litigation over a generic version of…

    By Suresh Pillai — Cook and W. L. Gore Prevail in Suit over Endovascular Grafts The Court of Appeals for the Federal Circuit has affirmed a lower court ruling that neither Cook Inc. nor W. L. Gore & Associates infringed Edwards Lifesciences LLC's patents covering endovascular grafts used to treat aneurysms without open vessel…

    By Suresh Pillai — Purdue Files Appeal in Ultram® Suit against Par Purdue Pharma Products Inc. has filed an appeal with the U.S. Court of Appeals for the Federal Circuit seeking to overturn an earlier federal court decision that invalidated Purdue's patents (U.S. Patent Nos. 7,074,430 and 6,254,887 covering their product, Ultram ER®. Purdue…

    By Suresh Pillai — Capricorn Keeps Zicam® IP Suit Active, But Loses Bid for Inventorship Change The U.S. District Court for the District of Delaware has ruled that Capricorn Pharma, Inc. can proceed with its suit against Matrixx Initiatives Inc. for allegedly infringing Capricorn's patent covering Zicam®, a cold medication.  The patent-in-suit, U.S. Patent…

    By Suresh Pillai — Settlement Announced in University of Iowa Dispute with Amgen The University of Iowa Research Foundation (UIRF) has announced a settlement in its dispute with Amgen Inc. over alleged patent infringement of two UIRF patents covering a cytomegalovirus promoter used in the design and manufacture of a number of marketed vaccines…

    By Suresh Pillai — Jury Finds AGA Guilty of Infringement in Medtronic Dispute A jury in the U.S. District Court for the Northern District of California has ruled that AGA Medical Corp. infringed Medtronic Inc.'s patents for blood vessel occlusion devices, and has ordered AGA to pay Medtronic $57 million.  This award is based…

    By Suresh Pillai — Settlement Announced in Ethyol® Infringement Suit Sun Pharmaceutical Industries, Ltd. and Medimmune LLC have announced a settlement of their patent dispute regarding Sun's manufacture and marketing of a generic version of the Medimmune drug Ethyol®, a cancer therapy drug.  Medimmune first filed suit in 2004, alleging that Sun and its…

    By Suresh Pillai — Judge Denies Attorneys Fees to Sandoz in Dispute with Sanofi-Aventis The U.S. District Court for the Central District of California denied Sandoz Inc.'s motion seeking attorneys' fees and costs in its patent infringement suit with Sanofi-Aventis.  The patents-in-suit, U.S. Patent Nos. 5,389,618 and RE 38,743, cover Sanofi's anti-clotting drug, Lovenox®. …

    By Suresh Pillai — Settlement Announced in Eloxatin® Suit The U.S. District Court for the District of New Jersey has issued an order announcing a settlement of all outstanding litigation between Sanofi-Aventis and Ebewe Pharma over Eloxatin®, a colon cancer drug marketed and distributed by Sanofi.  This settlement puts an end to two years…

    By Suresh Pillai — Stanford Graduate Student Adds Claims to Suit against Mentor and Professor over Patent Inventorship Christopher Sclimenti, a former graduate student in the laboratory of Stanford University faculty member Michele Calos, has amended his suit against both Stanford and his former mentor, claiming that Dr. Calos plagiarized Dr. Sclimenti's Ph.D. dissertation…